IC
Posted:
March 02, 2026
Location:
Remote, Brazil, Brazil
Job Description
Site Engagement Liaison (FSP - Sponsor Dedicated) São Paulo
ICON plc is a world-leading healthcare intelligence and clinical research organization. We’re proud to foster an inclusive environment driving innovation and excellence, and we welcome you to join us on our mission to shape the future of clinical development.
We are currently seeking a Site Engagement Liaison to join our diverse and dynamic team. As a Site Engagement Liaison at ICON, you will play a pivotal role in fostering relationships with clinical trial sites, enhancing site engagement, and contributing to the advancement of inNvative treatments and therapies.
**What you will be doing**
+ Building and maintaining strong relationships with key stakeholders at clinical trial sites, including principal investigators, site coordinators, and research staff.
+ Providing support and guidance to site staff on study protocols, procedures...
ICON plc is a world-leading healthcare intelligence and clinical research organization. We’re proud to foster an inclusive environment driving innovation and excellence, and we welcome you to join us on our mission to shape the future of clinical development.
We are currently seeking a Site Engagement Liaison to join our diverse and dynamic team. As a Site Engagement Liaison at ICON, you will play a pivotal role in fostering relationships with clinical trial sites, enhancing site engagement, and contributing to the advancement of inNvative treatments and therapies.
**What you will be doing**
+ Building and maintaining strong relationships with key stakeholders at clinical trial sites, including principal investigators, site coordinators, and research staff.
+ Providing support and guidance to site staff on study protocols, procedures...
Apply for this Job
Submit your application for the Site Engagement Liaison position at ICON Clinical Research.
Apply Now Save for LaterJob Overview
Job Type:
Full-time
Location:
Remote, Brazil
Posted:
March 02, 2026
Deadline:
April 04, 2026